NCT00039754View on ClinicalTrials.gov

A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

March 31, 2002

Conditions
Multiple Myeloma
Interventions
DRUG

Holmium-166-DOTMP

Sponsors
All Listed Sponsors
lead

Poniard Pharmaceuticals

INDUSTRY